Numerous growth drivers and strong tailwinds should combine to drive this artificial intelligence (AI) pioneer higher.

The #ASX200 logged a series of record highs this week, recovering from a sharp pullback in early August. Many investors are ...

Jazz Pharma's diversified drug portfolio drives revenue growth. Zanidatamab shows promise with potential FDA approval in late ...

Building a successful SaaS growth model requires a deep understanding of the customer journey and a commitment to product ...

State Street has strong regulatory capital and stress test results, supporting its financial stability. Learn why STT stock ...

One of the most consequential Federal Reserve meetings in recent history has put investors’ focus squarely on one question: ...

Small-cap valuations remain far below the US market average and may present an opportunity for ETF investors to buy low. This ...

Early Recovery: Public markets recovered aggressively from their lower troughs while private equity’s recovery was more muted ...

Great companies can become merely good or even below average. Here is how I'd go about avoiding situations like this.

Markets are pricing in roughly 250 basis points of easing by the end of 2025, LSEG data showed. For investors ... market has helped fuel sharp swings in the S&P 500, while global growth concerns are ...

Growth, scaling and expansion—these are the mantras echoed by startups and mature organizations alike. According to Accenture ...